{"entity":{"type":"insider","cik":"0001465836","url":"/insider/0001465836","json_url":"/insider/0001465836.json","name":"Boxer Asset Management Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":99,"n_filings":41,"first":"2009-07-29","last":"2023-10-17","span_basis":"filed_date"},"name_variants":[{"name":"Boxer Asset Management Inc.","source":"filing","n_filings":41,"first_seen":"2009-07-29","last_seen":"2023-10-17"}],"transactions":[{"id":9203170,"accession":"0000895345-23-000589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000589","line_url":"/filing/0000895345-23-000589#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":3420000.0,"total_display":"3,420,000.00","total_whole":"3,420,000","shares_owned_after":8198642.0,"shares_owned_after_display":"8,198,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-17","scope":"insider"},{"id":7833673,"accession":"0000895345-23-000588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000588","line_url":"/filing/0000895345-23-000588#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":3420000.0,"total_display":"3,420,000.00","total_whole":"3,420,000","shares_owned_after":8198642.0,"shares_owned_after_display":"8,198,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-17","scope":"insider"},{"id":9203171,"accession":"0000895345-23-000589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000589","line_url":"/filing/0000895345-23-000589#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":5302500.0,"total_display":"5,302,500.00","total_whole":"5,302,500","shares_owned_after":7698642.0,"shares_owned_after_display":"7,698,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-17","scope":"insider"},{"id":7833669,"accession":"0000895345-23-000588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000588","line_url":"/filing/0000895345-23-000588#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":5302500.0,"total_display":"5,302,500.00","total_whole":"5,302,500","shares_owned_after":7698642.0,"shares_owned_after_display":"7,698,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-17","scope":"insider"},{"id":7854388,"accession":"0000895345-23-000574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000574","line_url":"/filing/0000895345-23-000574","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":9.956666666666667,"price_display":"9.96","price_state":"stated","total_value":2240250.0,"total_display":"2,240,250.00","total_whole":"2,240,250","shares_owned_after":6948642.0,"shares_owned_after_display":"6,948,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-11","scope":"insider","n_lines":2},{"id":8309342,"accession":"0000895345-23-000524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000895345-23-000524","line_url":"/filing/0000895345-23-000524","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":16.264779657142856,"price_display":"16.26","price_state":"stated","total_value":5692672.88,"total_display":"5,692,672.88","total_whole":"5,692,673","shares_owned_after":1804058.0,"shares_owned_after_display":"1,804,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider","n_lines":3},{"id":8644021,"accession":"0000895345-23-000499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000499","line_url":"/filing/0000895345-23-000499","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8619788,"accession":"0000895345-23-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000498","line_url":"/filing/0000895345-23-000498#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":475000.0,"shares_display":"475,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":2446250.0,"total_display":"2,446,250.00","total_whole":"2,446,250","shares_owned_after":743542.0,"shares_owned_after_display":"743,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8421038,"accession":"0000895345-23-000500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000500","line_url":"/filing/0000895345-23-000500","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8740388,"accession":"0000895345-23-000356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000356","line_url":"/filing/0000895345-23-000356#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Rain Oncology Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":995000.0,"shares_display":"995,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":1243750.0,"total_display":"1,243,750.00","total_whole":"1,243,750","shares_owned_after":1152212.0,"shares_owned_after_display":"1,152,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":6364928,"accession":"0000899243-22-033595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":4.6461,"price_display":"4.65","price_state":"stated","total_value":325227.0,"total_display":"325,227.00","total_whole":"325,227","shares_owned_after":7123642.0,"shares_owned_after_display":"7,123,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-13","scope":"insider"},{"id":6364927,"accession":"0000899243-22-033595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.4328,"price_display":"4.43","price_state":"stated","total_value":221640.0,"total_display":"221,640.00","total_whole":"221,640","shares_owned_after":268524.0,"shares_owned_after_display":"268,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-13","scope":"insider"},{"id":6364926,"accession":"0000899243-22-033595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117000.0,"shares_display":"117,000","price_per_share":4.2539,"price_display":"4.25","price_state":"stated","total_value":497706.3,"total_display":"497,706.30","total_whole":"497,706","shares_owned_after":218524.0,"shares_owned_after_display":"218,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6714806,"accession":"0000899243-22-033177","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-033177","line_url":"/filing/0000899243-22-033177#line-4","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70394.0,"shares_display":"70,394","price_per_share":4.0638,"price_display":"4.06","price_state":"stated","total_value":286067.1372,"total_display":"286,067.14","total_whole":"286,067","shares_owned_after":7053642.0,"shares_owned_after_display":"7,053,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-06","scope":"insider"},{"id":6714803,"accession":"0000899243-22-033177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033177","line_url":"/filing/0000899243-22-033177","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86000.0,"shares_display":"86,000","price_per_share":3.8843343023255814,"price_display":"3.88","price_state":"stated","total_value":334052.75,"total_display":"334,052.75","total_whole":"334,053","shares_owned_after":6942748.0,"shares_owned_after_display":"6,942,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider","n_lines":2},{"id":6714797,"accession":"0000899243-22-033177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033177","line_url":"/filing/0000899243-22-033177#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25606.0,"shares_display":"25,606","price_per_share":3.6701,"price_display":"3.67","price_state":"stated","total_value":93976.5806,"total_display":"93,976.58","total_whole":"93,977","shares_owned_after":6897248.0,"shares_owned_after_display":"6,897,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":6318118,"accession":"0000899243-22-011657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011657","line_url":"/filing/0000899243-22-011657#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":575201.0,"shares_display":"575,201","price_per_share":35.25,"price_display":"35.25","price_state":"stated","total_value":20275835.25,"total_display":"20,275,835.25","total_whole":"20,275,835","shares_owned_after":3142058.0,"shares_owned_after_display":"3,142,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-18","scope":"insider"},{"id":6913244,"accession":"0000899243-22-001072","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-22-001072","line_url":"/filing/0000899243-22-001072","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC; Boxer Asset Management Inc.","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184677.0,"shares_display":"184,677","price_per_share":42.76798763462694,"price_display":"42.77","price_state":"stated","total_value":7898263.6524,"total_display":"7,898,263.65","total_whole":"7,898,264","shares_owned_after":3767405.0,"shares_owned_after_display":"3,767,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider","n_lines":8},{"id":6913206,"accession":"0000899243-22-001072","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-001072","line_url":"/filing/0000899243-22-001072","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC; Boxer Asset Management Inc.","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":515323.0,"shares_display":"515,323","price_per_share":47.88720607774153,"price_display":"47.89","price_state":"stated","total_value":24677378.6976,"total_display":"24,677,378.70","total_whole":"24,677,379","shares_owned_after":3912113.0,"shares_owned_after_display":"3,912,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider","n_lines":6},{"id":4206143,"accession":"0000899243-21-049181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-049181","line_url":"/filing/0000899243-21-049181#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; LEWIS JOSEPH; Boxer Asset Management Inc.","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":13.1225,"price_display":"13.12","price_state":"stated","total_value":1640312.5,"total_display":"1,640,312.50","total_whole":"1,640,313","shares_owned_after":6448359.0,"shares_owned_after_display":"6,448,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":4088733,"accession":"0000899243-21-046083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046083","line_url":"/filing/0000899243-21-046083#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":1.5684,"price_display":"1.57","price_state":"stated","total_value":313680.0,"total_display":"313,680.00","total_whole":"313,680","shares_owned_after":4207086.0,"shares_owned_after_display":"4,207,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-24","scope":"insider"},{"id":4088729,"accession":"0000899243-21-046083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-046083","line_url":"/filing/0000899243-21-046083#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":1.5483,"price_display":"1.55","price_state":"stated","total_value":309660.0,"total_display":"309,660.00","total_whole":"309,660","shares_owned_after":4407086.0,"shares_owned_after_display":"4,407,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-24","scope":"insider"},{"id":4605311,"accession":"0000899243-21-045437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-045437","line_url":"/filing/0000899243-21-045437#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":1.8419,"price_display":"1.84","price_state":"stated","total_value":276285.0,"total_display":"276,285.00","total_whole":"276,285","shares_owned_after":4607086.0,"shares_owned_after_display":"4,607,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-19","scope":"insider"},{"id":4605307,"accession":"0000899243-21-045437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045437","line_url":"/filing/0000899243-21-045437#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":1.949,"price_display":"1.95","price_state":"stated","total_value":487250.0,"total_display":"487,250.00","total_whole":"487,250","shares_owned_after":4757086.0,"shares_owned_after_display":"4,757,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider"},{"id":4605299,"accession":"0000899243-21-045437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-045437","line_url":"/filing/0000899243-21-045437#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":2.1654,"price_display":"2.17","price_state":"stated","total_value":1299240.0,"total_display":"1,299,240.00","total_whole":"1,299,240","shares_owned_after":5007086.0,"shares_owned_after_display":"5,007,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider"},{"id":5455670,"accession":"0000899243-21-036419","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036419","line_url":"/filing/0000899243-21-036419#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":6323359.0,"shares_owned_after_display":"6,323,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-17","scope":"insider"},{"id":4122888,"accession":"0000899243-21-017120","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-017120","line_url":"/filing/0000899243-21-017120#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Capital, LLC; Boxer Asset Management Inc.","owner_display_name":"LEWIS JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1025000.0,"shares_display":"1,025,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":17425000.0,"total_display":"17,425,000.00","total_whole":"17,425,000","shares_owned_after":1175000.0,"shares_owned_after_display":"1,175,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-27","scope":"insider"},{"id":4122887,"accession":"0000899243-21-017120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-017120","line_url":"/filing/0000899243-21-017120","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Capital, LLC; Boxer Asset Management Inc.","owner_display_name":"LEWIS JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":16.155,"price_display":"16.16","price_state":"stated","total_value":2423250.0,"total_display":"2,423,250.00","total_whole":"2,423,250","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-27","scope":"insider","n_lines":2},{"id":4350749,"accession":"0000899243-21-010812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-6","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363000.0,"shares_display":"363,000","price_per_share":181.15,"price_display":"181.15","price_state":"stated","total_value":65757450.0,"total_display":"65,757,450.00","total_whole":"65,757,450","shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4350742,"accession":"0000899243-21-010812","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-5","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37000.0,"shares_display":"37,000","price_per_share":181.15,"price_display":"181.15","price_state":"stated","total_value":6702550.0,"total_display":"6,702,550.00","total_whole":"6,702,550","shares_owned_after":230333.0,"shares_owned_after_display":"230,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4350737,"accession":"0000899243-21-010812","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-4","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4.0,"shares_display":"4","price_per_share":181.0,"price_display":"181.00","price_state":"stated","total_value":724.0,"total_display":"724.00","total_whole":"724","shares_owned_after":2363000.0,"shares_owned_after_display":"2,363,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"}],"collapsed":true,"next_cursor":"2021-03-05|4350737","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2022-10-06","last_seen":"2023-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001808865","name":"iTeos Therapeutics, Inc.","url":"/issuer/0001808865","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2020-07-29","last_seen":"2023-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner, Other","n_filings":9,"first_seen":"2013-10-28","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Oncology Inc.","url":"/issuer/0001724979","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2021-04-27","last_seen":"2023-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Ten percent owner","n_filings":2,"first_seen":"2021-09-17","last_seen":"2021-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001717452","name":"Odonate Therapeutics, Inc.","url":"/issuer/0001717452","role":"Ten percent owner","n_filings":10,"first_seen":"2017-12-08","last_seen":"2021-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Other","n_filings":1,"first_seen":"2020-09-29","last_seen":"2020-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":1,"first_seen":"2018-11-05","last_seen":"2018-11-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":1,"first_seen":"2016-06-14","last_seen":"2016-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001563855","name":"SOPHIRIS BIO INC.","url":"/issuer/0001563855","role":"Ten percent owner","n_filings":2,"first_seen":"2013-08-20","last_seen":"2014-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Other","n_filings":2,"first_seen":"2009-07-29","last_seen":"2009-08-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465836","retrieved_at":"2026-08-22T11:50:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}